The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
- PMID: 3086432
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
Abstract
We examined the antigenic and functional characteristics of human peripheral blood lymphocytes that differentially express the CD16 (Leu-11) and Leu-19 (NKH-1) antigens. Leu-19 is a approximately 220,000 daltons protein expressed on approximately 15% of freshly isolated peripheral blood lymphocytes. Within the Leu-19+ subset, three distinct populations were identified: CD3-,CD16+,Leu-19+ cells; CD3+,CD16-,Leu-19+ cells; and CD3-,CD16-,Leu-19bright+ cells. Both the CD3+,CD16-,Leu-19+ and CD3-,CD16+,Leu-19+ populations mediated non-major histocompatibility complex (MHC)-restricted cytotoxicity against the NK-sensitive tumor cell K562 and were large granular lymphocytes. CD3-,CD16+,Leu-19+ NK cells were the most abundant (comprising approximately 10% of peripheral blood lymphocytes) and the most efficient cytotoxic effectors. The finding that CD3+,Leu 19+ lymphocytes mediated cytotoxicity against K562 unequivocally demonstrates that a unique subset of non-MHC-restricted cytotoxic CD3+ T lymphocytes are present in the peripheral blood of unprimed, normal individuals. However, CD3+,CD16-,Leu-19+ cells comprised less than 5% of peripheral blood lymphocytes, and the cytotoxic activity of this subset was significantly less than CD3-,CD16+,Leu-19+ NK cells. Most CD3+,Leu-19+ T cells co-expressed the CD2, CD8, and CD5 differentiation antigens. The antigenic and functional phenotype of peripheral blood CD3+,Leu-19+ cytotoxic T lymphocytes corresponds to the interleukin 2-dependent CD3+ cell lines that mediate non-MHC-restricted cytotoxicity against NK-sensitive tumor cell targets. A small population of Leu-19bright+ lymphocytes lacking both CD3 and CD16 was also observed. This population (comprising less than 2% of peripheral blood lymphocytes) contained both large agranular lymphocytes and large granular lymphocytes. CD3-,CD16-,Leu-19bright+ lymphocytes also mediate non-MHC-restricted cytotoxicity. The relationship of these CD3-CD16-,Leu-19bright+ lymphocytes to CD3+ T cells or CD16+ NK cells is unknown.
Similar articles
-
Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.Fed Proc. 1986 Nov;45(12):2823-8. Fed Proc. 1986. PMID: 3095151 Review.
-
Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.J Immunol. 1986 Oct 15;137(8):2428-33. J Immunol. 1986. PMID: 3093576
-
Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.J Immunol. 1987 Apr 1;138(7):2019-23. J Immunol. 1987. PMID: 2951430
-
Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.J Immunol. 1986 Mar 1;136(5):1579-85. J Immunol. 1986. PMID: 2419407
-
Human cytotoxic effector cells: definition and analysis of activity.Allergol Immunopathol (Madr). 1991 Jul-Aug;19(4):145-56. Allergol Immunopathol (Madr). 1991. PMID: 1726345 Review.
Cited by
-
The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.Front Immunol. 2024 May 16;15:1358668. doi: 10.3389/fimmu.2024.1358668. eCollection 2024. Front Immunol. 2024. PMID: 38817602 Free PMC article. Review.
-
Tissue-resident memory NK cells: Homing in on local effectors and regulators.Immunol Rev. 2024 May;323(1):54-60. doi: 10.1111/imr.13332. Epub 2024 Apr 3. Immunol Rev. 2024. PMID: 38568046 Review.
-
Twenty-One Flavors of Type 1 Innate Lymphoid Cells with PD-1 (Programmed Cell Death-1 Receptor) Sprinkles.Discov Immunol. 2023 Feb 7;2(1):kyad003. doi: 10.1093/discim/kyad003. eCollection 2023. Discov Immunol. 2023. PMID: 38567059 Free PMC article. Review.
-
Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro.Front Immunol. 2024 Mar 7;15:1341804. doi: 10.3389/fimmu.2024.1341804. eCollection 2024. Front Immunol. 2024. PMID: 38515757 Free PMC article.
-
Natural killer cell therapies.Nature. 2024 Feb;626(8000):727-736. doi: 10.1038/s41586-023-06945-1. Epub 2024 Feb 21. Nature. 2024. PMID: 38383621 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials